Search This Blog

Wednesday, May 6, 2026

Usana beats, affirms guidance

 

Usana Health Sciences reports Q1 2026 EPS $0.61 and revenue $250.0M, beats EPS and revenue estimates, reiterates full-year 2026 guidance

  • Q1 2026 net sales and adjusted EPS both declined year over year.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)